Claimont Health Ltd
Registered number: 08107565
Balance Sheet
as at 30 June 2024
Notes 2024 2023
£ £
Fixed assets
Intangible assets 3 - -
Tangible assets 4 38,831 29,173
38,831 29,173
Current assets
Debtors 5 567,856 258,137
Cash at bank and in hand 23,380 514,192
591,236 772,329
Creditors: amounts falling due within one year 6 (369,924) (573,284)
Net current assets 221,312 199,045
Total assets less current liabilities 260,143 228,218
Creditors: amounts falling due after more than one year 7 (104,494) (164,255)
Provisions for liabilities (9,708) (5,543)
Net assets 145,941 58,420
Capital and reserves
Called up share capital 150 150
Profit and loss account 145,791 58,270
Shareholder's funds 145,941 58,420
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr V Gradillas Gonzalez
Director
Approved by the board on 21 March 2025
Claimont Health Ltd
Notes to the Accounts
for the year ended 30 June 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services and is recognised when the service is performed.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Office Equipment and fittings over 5 years
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Leased assets
A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership. All other leases are classified as operating leases. The rights of use and obligations under finance leases are initially recognised as assets and liabilities at amounts equal to the fair value of the leased assets or, if lower, the present value of the minimum lease payments. Minimum lease payments are apportioned between the finance charge and the reduction in the outstanding liability using the effective interest rate method. The finance charge is allocated to each period during the lease so as to produce a constant periodic rate of interest on the remaining balance of the liability. Leased assets are depreciated in accordance with the company's policy for tangible fixed assets. If there is no reasonable certainty that ownership will be obtained at the end of the lease term, the asset is depreciated over the lower of the lease term and its useful life. Operating lease payments are recognised as an expense on a straight line basis over the lease term.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 51 27
3 Intangible fixed assets £
Software
Cost
At 1 July 2023 9,600
At 30 June 2024 9,600
Amortisation
At 1 July 2023 9,600
At 30 June 2024 9,600
Net book value
At 30 June 2024 -
At 30 June 2023 -
Software was written off in equal annual instalments over its estimated economic life of 5 years.
4 Tangible fixed assets
Office Equipment & Fittings Total
£ £
Cost
At 1 July 2023 68,188 68,188
Additions 16,777 16,777
At 30 June 2024 84,965 84,965
Depreciation
At 1 July 2023 39,015 39,015
Charge for the year 7,119 7,119
At 30 June 2024 46,134 46,134
Net book value
At 30 June 2024 38,831 38,831
At 30 June 2023 29,173 29,173
5 Debtors 2024 2023
£ £
Trade debtors 412,497 106,152
Amounts owed by group undertakings and undertakings in which the company has a participating interest 120,258 117,339
Other debtors 35,101 34,646
567,856 258,137
6 Creditors: amounts falling due within one year 2024 2023
£ £
Bank loans and overdrafts (see note 8) 59,962 103,643
Trade creditors 103,660 27,682
Taxation and social security costs 73,520 30,280
Other creditors 132,782 411,679
369,924 573,284
7 Creditors: amounts falling due after one year 2024 2023
£ £
Bank loans (see note 8) 104,494 164,255
104,494 164,255
8 Loans
The bank loan was granted under the coronavirus business interruption loan facility scheme. The loan is guaranteed by the Department for Business, Energy and Industrial Strategy. No capital or interest was payable in the first 12 months of the loan. After year one, the loan is repayable in instalments over a further 5 year period.
9 Other financial commitments 2024 2023
£ £
Total future minimum payments under non-cancellable operating leases 4,500 4,500
10 Controlling party
The immediate parent undertaking is Claimont (UK) Limited,a company incorporated in England and Wales. The director of the company,V Gradillas Gonzalez, is the beneficial owner of the ultimate parent undertaking, Claimont Group Limited, a company incorporated in Jersey.
11 Other information
Claimont Health Ltd is a private company limited by shares and incorporated in England. Its registered office is:
9 Park Place
Newdigate Road
Harefield
Middlesex
UB9 6EJ
Claimont Health Ltd 08107565 false 2023-07-01 2024-06-30 2024-06-30 VT Final Accounts July 2024 Dr V Gradillas Gonzalez No description of principal activity 08107565 2022-07-01 2023-06-30 08107565 core:WithinOneYear 2023-06-30 08107565 core:AfterOneYear 2023-06-30 08107565 core:ShareCapital 2023-06-30 08107565 core:RetainedEarningsAccumulatedLosses 2023-06-30 08107565 core:AllPeriods 2023-06-30 08107565 2023-07-01 2024-06-30 08107565 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 08107565 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 08107565 bus:Director40 2023-07-01 2024-06-30 08107565 1 2023-07-01 2024-06-30 08107565 2 2023-07-01 2024-06-30 08107565 core:PlantMachinery 2023-07-01 2024-06-30 08107565 countries:England 2023-07-01 2024-06-30 08107565 bus:FRS102 2023-07-01 2024-06-30 08107565 bus:FilletedAccounts 2023-07-01 2024-06-30 08107565 2024-06-30 08107565 core:WithinOneYear 2024-06-30 08107565 core:AfterOneYear 2024-06-30 08107565 core:ShareCapital 2024-06-30 08107565 core:RetainedEarningsAccumulatedLosses 2024-06-30 08107565 core:Goodwill 2024-06-30 08107565 core:PlantMachinery 2024-06-30 08107565 core:AllPeriods 2024-06-30 08107565 2023-06-30 08107565 core:Goodwill 2023-06-30 08107565 core:PlantMachinery 2023-06-30 iso4217:GBP xbrli:pure